Welcome to LookChem.com Sign In|Join Free

CAS

  • or

96445-15-7

Post Buying Request

96445-15-7 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

96445-15-7 Usage

Uses

An Oxymorphone derivative. It is less potent than Oxymorphone.

Check Digit Verification of cas no

The CAS Registry Mumber 96445-15-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,6,4,4 and 5 respectively; the second part has 2 digits, 1 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 96445-15:
(7*9)+(6*6)+(5*4)+(4*4)+(3*5)+(2*1)+(1*5)=157
157 % 10 = 7
So 96445-15-7 is a valid CAS Registry Number.
InChI:InChI=1/C17H17NO5/c1-18-7-6-16-11-8-2-3-9(19)13(11)23-15(16)10(20)4-5-17(16,22)14(18)12(8)21/h2-3,14-15,19,22H,4-7H2,1H3/t14-,15+,16+,17-/m1/s1

96445-15-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 10-Keto-oxymorphone

1.2 Other means of identification

Product number -
Other names 10-OXO OXYMORPHONE

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:96445-15-7 SDS

96445-15-7Downstream Products

96445-15-7Relevant articles and documents

10-ketonaltrexone and 10-ketooxymorphone

Archer,Seyed-Mozaffari,Ward,Kosterlitz,Paterson,McKnight,Corbett

, p. 974 - 976 (2007/10/02)

Ethylketocyclazocine has greater κ/μ selectivity than cyclazocine in brain binding assays. 10-Ketonaltrexone (11) and 10-ketooxymorphone (10) were prepared from naltrexone 3-methyl ether and oxycodone, respectively. Bioassays in the myenteric plexus longitudinal muscle preparation of the guinea pig ileum and in the mouse vas deferens, in addition to brain binding assays, demonstrated that 10 and 11 were far less potent than naltrexone and oxymorphone at μ sites and also had little affinity for κ and δ sites. It is concluded that introduction of the 10-keto group in naltrexone and oxymorphone diminished opioid effects at all binding sites.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 96445-15-7